UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Hepatitis C Virus-Induced Membranous Web and Associated Nuclear Transport Machinery Limit Access of Pattern Recognition Receptors to Viral Replication Sites

PLoS pathogens, 2016-02, Vol.12 (2), p.e1005428-e1005428

2016

Volltextzugriff (PDF)

Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus

PloS one, 2013-05, Vol.8 (5), p.e64449

2013

Volltextzugriff (PDF)

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

Nature communications, 2022-11, Vol.13 (1), p.6992-6992, Article 6992

2022

Volltextzugriff (PDF)

IL-28B is a key regulator of B- and T-cell vaccine responses against influenza

PLoS pathogens, 2014-12, Vol.10 (12), p.e1004556-e1004556

2014

Volltextzugriff (PDF)

Hepatitis C virus-induced cytoplasmic organelles use the nuclear transport machinery to establish an environment conducive to virus replication

PLoS pathogens, 2013-10, Vol.9 (10), p.e1003744-e1003744

2013

Volltextzugriff (PDF)

DNase-Mediated Single-Cycle Selection of Aptamers for Proteins Blotted on a Membrane

Analytical chemistry (Washington), 2012-09, Vol.84 (18), p.7603-7606

2012

Volltextzugriff (PDF)

Functional characterization of nuclear localization and export signals in hepatitis C virus proteins and their role in the membranous web

PloS one, 2014-12, Vol.9 (12), p.e114629-e114629

2014

Volltextzugriff (PDF)

Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis

PloS one, 2013-06, Vol.8 (6), p.e68308-e68308

2013

Volltextzugriff (PDF)

Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19

BMC pharmacology & toxicology, 2021-10, Vol.22 (1), p.1-20, Article 61

2021

Volltextzugriff (PDF)

Zinc Finger Proteins Designed To Specifically Target Duck Hepatitis B Virus Covalently Closed Circular DNA Inhibit Viral Transcription in Tissue Culture

Journal of Virology, 2008-08, Vol.82 (16), p.8013-8021

2008

Volltextzugriff (PDF)

Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry

Journal of hepatology, 2015-03, Vol.62 (3), p.541-548

2015

Volltextzugriff (PDF)

Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers

International journal for parasitology, 2006-03, Vol.36 (3), p.353-360

2006

Volltextzugriff (PDF)

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

Proceedings of the National Academy of Sciences - PNAS, 2010-10, Vol.107 (40), p.17339-17344

2010

Volltextzugriff (PDF)

Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease

PloS one, 2010-02, Vol.5 (2), p.e9209

2010

Volltextzugriff (PDF)

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti‐hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

Hepatology (Baltimore, Md.), 2009-03, Vol.49 (3), p.745-752

2009

Volltextzugriff (PDF)

Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis

Journal of interferon & cytokine research, 2014-03, Vol.34 (3), p.204-214

2014

Volltextzugriff (PDF)

Superinfection Exclusion in Duck Hepatitis B Virus Infection Is Mediated by the Large Surface Antigen

Journal of Virology, 2004-08, Vol.78 (15), p.7925-7937

2004

Volltextzugriff (PDF)

The cell biology of hepatitis C virus

Microbes and infection, 2010-04, Vol.12 (4), p.263-271

2010

Volltextzugriff (PDF)

Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical application

Hepatology (Baltimore, Md.), 2006-06, Vol.43 (6), p.1346-1353

2006

Volltextzugriff (PDF)

Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine

International immunology, 2008-01, Vol.20 (1), p.89-104

2008

Volltextzugriff (PDF)

Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine

Vaccine, 2012-02, Vol.30 (6), p.998-1008

2012

Volltextzugriff (PDF)

Induction of Primary Human T Cell Responses against Hepatitis C Virus-Derived Antigens NS3 or Core by Autologous Dendritic Cells Expressing Hepatitis C Virus Antigens: Potential for Vaccine and Immunotherapy

Journal of Immunology, 2006-05, Vol.176 (10), p.6065-6075

2006

Volltextzugriff (PDF)

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome

Cytokine (Philadelphia, Pa.), 2016-02, Vol.78, p.27-36

2016

Volltextzugriff (PDF)

Antiviral activity of 2,3′-anhydro and related pyrimidine nucleosides against hepatitis B virus

Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6790-6793

2010

Volltextzugriff (PDF)

Effect of Various Pyrimidines Possessing the 1-[(2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl] Moiety, Able To Mimic Natural 2‘-Deoxyribose, on Wild-type and Mutant Hepatitis B Virus Replication

Journal of medicinal chemistry, 2006-06, Vol.49 (12), p.3693-3700

2006

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(95)
Buchkapitel
(1)

Sprache

Englisch
(96)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Hepatitis C Virus-Induced Membranous Web and Associated Nuclear Transport Machinery Limit Access of Pattern Recognition Receptors to Viral Replication Sites

Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

IL-28B is a key regulator of B- and T-cell vaccine responses against influenza

Hepatitis C virus-induced cytoplasmic organelles use the nuclear transport machinery to establish an environment conducive to virus replication

DNase-Mediated Single-Cycle Selection of Aptamers for Proteins Blotted on a Membrane

Functional characterization of nuclear localization and export signals in hepatitis C virus proteins and their role in the membranous web

Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis

Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19

Zinc Finger Proteins Designed To Specifically Target Duck Hepatitis B Virus Covalently Closed Circular DNA Inhibit Viral Transcription in Tissue Culture

Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry

Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti‐hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis

Superinfection Exclusion in Duck Hepatitis B Virus Infection Is Mediated by the Large Surface Antigen

The cell biology of hepatitis C virus

Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical application

Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine

Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine

Induction of Primary Human T Cell Responses against Hepatitis C Virus-Derived Antigens NS3 or Core by Autologous Dendritic Cells Expressing Hepatitis C Virus Antigens: Potential for Vaccine and Immunotherapy

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome

Antiviral activity of 2,3′-anhydro and related pyrimidine nucleosides against hepatitis B virus

Effect of Various Pyrimidines Possessing the 1-[(2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl] Moiety, Able To Mimic Natural 2‘-Deoxyribose, on Wild-type and Mutant Hepatitis B Virus Replication

Suchergebnisse filtern